SCHEMBL7992191

SCHEMBL7992191

CC(C)Sc1nc2ncccc2o1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 4/20 0.51
SHMT2 P34897 3/20 0.50
POLB P06746 1/20 0.45
LMNA P02545 2/20 0.43
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
ACACB O00763 1/20 0.42
KDM4E B2RXH2 2/20 0.42
ELANE P08246 1/20 0.42
THRB P10828 1/20 0.41
HPGD P15428 2/20 0.41
HSD17B10 Q99714 2/20 0.41
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
ALOX12 P18054 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HAVCR2 Q8TDQ0 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
FAAH O00519 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL219441 0.81 POLB (0.48) SHMT2POLBLMNANPC1RAB9A
SCHEMBL4758192 0.74 POLB (0.46) TP53SHMT2POLBLMNANPC1
SCHEMBL9212294 0.74 SHMT2 (0.51) TP53SHMT2POLBLMNAACACB
SCHEMBL2624377 0.74 NPC1 (0.46) TP53NPC1RAB9AKDM4EHPGD
SCHEMBL18013085 0.74 ELANE (0.61) POLBLMNANPC1RAB9AELANE
SCHEMBL3963205 0.71 SORD (0.49) SHMT2NPC1RAB9AKDM4EHPGD
SCHEMBL316306 0.71 KDM4E (0.53) TP53NPC1RAB9AKDM4EHPGD
SCHEMBL3407130 0.70 SHMT2 (0.56) TP53SHMT2POLBLMNANPC1
SCHEMBL1427654 0.69 NPC1 (0.51) TP53NPC1RAB9AKDM4EHPGD
SCHEMBL9210293 0.68 LMNA (0.65) TP53SHMT2POLBLMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130289013-A1 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS SUNOVION PHARMACEUTICALS INC. 2013-10-31 US disclosed
US-20110166146-A1 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS SUNOVION PHARMACEUTICALS INC. (US) 2011-07-07 US disclosed
WO-2009143156-A2 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS SEPRACOR INC. (US) 2009-11-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166146-A1 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS PAICS, ITPA, DPYD TP53 1791/4885SHMT2 619/4885POLB 2243/4885
US-20130289013-A1 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS PAICS, ITPA, DPYD TP53 1791/4885SHMT2 619/4885POLB 2243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.